Long B - Search Results

1

Aromatase inhibitors and their antitumor effects in model systems.

Brodie A, Lu Q, Liu Y, Long B. Brodie A, et al. Among authors: long b. Endocr Relat Cancer. 1999 Jun;6(2):205-10. doi: 10.1677/erc.0.0060205. Endocr Relat Cancer. 1999. PMID: 10731110

2

The intratumoral aromatase model: studies with aromatase inhibitors and antiestrogens.

Brodie AH, Jelovac D, Long B. Brodie AH, et al. Among authors: long b. J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):283-8. doi: 10.1016/s0960-0760(03)00368-6. J Steroid Biochem Mol Biol. 2003. PMID: 14623522

3

Model systems: mechanisms involved in the loss of sensitivity to letrozole.

Brodie A, Jelovac D, Sabnis G, Long B, Macedo L, Goloubeva O. Brodie A, et al. Among authors: long b. J Steroid Biochem Mol Biol. 2005 May;95(1-5):41-8. doi: 10.1016/j.jsbmb.2005.04.026. J Steroid Biochem Mol Biol. 2005. PMID: 15967659

4

The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.

Long BJ, Jelovac D, Thiantanawat A, Brodie AM. Long BJ, et al. Clin Cancer Res. 2002 Jul;8(7):2378-88. Clin Cancer Res. 2002. PMID: 12114443

The aim of this study was to determine whether aromatase-transfected and hormone-dependent MCF-7Ca human breast cancer cells remain sensitive to antiestrogens after: (a) long-term growth in steroid-depleted medium in vitro; and (b) long-term treatment with th …

The aim of this study was to determine whether aromatase-transfected and hormone-dependent MCF-7Ca human breast cancer cells remain sensitiv …

5

Predictions from a preclinical model: studies of aromatase inhibitors and antiestrogens.

Brodie A, Jelovac D, Long BJ. Brodie A, et al. Clin Cancer Res. 2003 Jan;9(1 Pt 2):455S-9S. Clin Cancer Res. 2003. PMID: 12538500

6

Signaling pathways of apoptosis activated by aromatase inhibitors and antiestrogens.

Thiantanawat A, Long BJ, Brodie AM. Thiantanawat A, et al. Cancer Res. 2003 Nov 15;63(22):8037-50. Cancer Res. 2003. PMID: 14633737

7

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.

Long BJ, Jelovac D, Handratta V, Thiantanawat A, MacPherson N, Ragaz J, Goloubeva OG, Brodie AM. Long BJ, et al. J Natl Cancer Inst. 2004 Mar 17;96(6):456-65. doi: 10.1093/jnci/djh076. J Natl Cancer Inst. 2004. PMID: 15026471

8

Effects of exemestane and tamoxifen in a postmenopausal breast cancer model.

Jelovac D, Macedo L, Handratta V, Long BJ, Goloubeva OG, Ingle JN, Brodie AM. Jelovac D, et al. Clin Cancer Res. 2004 Nov 1;10(21):7375-81. doi: 10.1158/1078-0432.CCR-04-0565. Clin Cancer Res. 2004. PMID: 15534114

9

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole.

Jelovac D, Sabnis G, Long BJ, Macedo L, Goloubeva OG, Brodie AM. Jelovac D, et al. Cancer Res. 2005 Jun 15;65(12):5380-9. doi: 10.1158/0008-5472.CAN-04-4502. Cancer Res. 2005. PMID: 15958587

10

Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer.

Brodie A, Lu Q, Liu Y, Long B, Wang JP, Yue W. Brodie A, et al. Among authors: long b. Oncology (Williston Park). 1998 Mar;12(3 Suppl 5):36-40. Oncology (Williston Park). 1998. PMID: 9556790 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,004 results

Search Page

Filters